Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma
A multi-institutional research team, led by investigators at Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, […]
» Read morenohealthproblemsnews.com
Home »
A multi-institutional research team, led by investigators at Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, […] A combination of a novel inhibitor of the protein CK2 (Casein kinase 2) and an immune checkpoint inhibitor has dramatically […] Scientists at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to […]
Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma
Enhancing immune checkpoint inhibitor therapy using treatment combination
Study finds melanoma biomarkers predicting checkpoint blocker response